PLA2G2D and ovarian cancer: Of note, the small molecule drug targeted by PLA2G2D mepacrine (also named as quinacrine), which was originally used as an anti-malarial drug has been recently repurposed as an anticancer agent in treating ovarian cancer, gynecologic, breast cancer, and colon cancer [39, 40].